Shai Shimony, MD

Medical Oncology

Shai Shimony, MD

Dr Shimony's clinical focus is on care of patients with acute leukemia with special interest in acute myeloid leukemia, acute lymphoblastic leukemia and blastic plasmacytoid dentritic cell neoplasm. Dr Shimony's research interest is utilizing real-world data to perform correlative studies and understanding the impact of genetic mutations on patient outcomes.

View full profile

Related Videos

Shai Shimony, MD, MPH reviews Phase 3 acute myeloid leukemia trial Video

Shai Shimony, MD, MPH reviews Phase 3 acute myeloid leukemia trial

Findings from a Phase 3 acute myeloid leukemia trial presented at #ASH24 show CPX-351 improves survival for AML-MR patients. Lead authors Shai Shimony, MD, MPH, and H. Moses Murdoch, MD, of Dana-Farber Cancer Institute, explain more in this video.

Shai Shimony, MD, Molecular Ontogeny in AML Video

Shai Shimony, MD, Molecular Ontogeny in AML

A study led by Shai Shimony, MD, Dana-Farber, revealed the significant impact of molecular ontogeny classification on outcomes among newly diagnosed acute myeloid leukemia patients treated with hypomethylating agents (HMA) +/- venetoclax (VEN).